Piper Sandler Starts Penumbra (PEN) at Overweight

(Updated - January 30, 2023 6:53 AM EST)

Piper Sandler analyst Matt O'Brien initiates coverage on Penumbra (NYSE: PEN) with a Overweight rating and a price target of $275.00.

The analyst comments "We are initiating coverage of PEN with an OW rating and $275 price target. Penumbra anticipates launching three products this year that address an >$8B market opportunity just in the US, which we believe will set them up for strong growth going forward."

For an analyst ratings summary and ratings history on Penumbra click here. For more ratings news on Penumbra click here.

Shares of Penumbra closed at $250.44 yesterday.

You May Also Be Interested In

• Bombardier (BBB/B:CN) (BDRBF) PT Raised to Cdn$78 at Goldman Sachs
• Wuxi Biologics (2269:HK) (WXXWY) PT Lowered to HK$90 at Jefferies
• Vesuvius Plc. (VSVS:LN) PT Raised to GBP5.85 at Jefferies